<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00910130</url>
  </required_header>
  <id_info>
    <org_study_id>RBP4</org_study_id>
    <nct_id>NCT00910130</nct_id>
  </id_info>
  <brief_title>Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4</brief_title>
  <official_title>Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Retinol binding protein 4 has a role in
      insulin resistance development in patients suffering from end stage renal disease on
      hemodialysis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Diabetes</condition>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>End Stage Renal Disease</arm_group_label>
    <description>Patients suffering from End Stage Renal Disease on Hemodialysis, without Diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy people, with normal Renal Function and without Diabetes, matched with &quot;ESRD group&quot; for age, gender, BMI</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum Subcutaneous adipose tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Ambulatory patients or primary care clinic for &quot;End Stage Renal Disease group;&quot; Blood
        donors or primary care clinic for &quot;Control group&quot;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hemodialysis for &quot;End Stage Renal Disease group&quot;

          -  Normal Renal Function for &quot;Control group&quot;

        Exclusion Criteria:

          -  Diabetes

          -  Malnutrition

          -  Malignancy

          -  Acute Infection

          -  Chronic Active Infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Piotti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unit Of Nephrology, Dialysis And Transpantation, IRCCS Fondazione Policlinico San Matteo, Pavia Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Teresa Rampino, MD</last_name>
    <role>Study Director</role>
    <affiliation>Unit Of Nephrology, Dialysis And Transpantation, IRCCS Fondazione Policlinico San Matteo, Pavia Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Dal Canton, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Unit Of Nephrology, Dialysis And Transpantation, IRCCS Fondazione Policlinico San Matteo, Pavia Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giovanni Piotti, MD</last_name>
    <phone>+390382502590</phone>
    <email>gpiotti@yahoo.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Teresa Rampino, MD</last_name>
    <phone>+390382503896</phone>
    <email>t.rampino@smatteo.pv.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Giovanni Piotti</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Piotti, MD</last_name>
      <phone>+390382502590</phone>
      <email>gpiotti@yahoo.it</email>
    </contact>
    <contact_backup>
      <last_name>Teresa Rampino, MD</last_name>
      <phone>+390382503896</phone>
      <email>t.rampino@smatteo.pv.it</email>
    </contact_backup>
    <investigator>
      <last_name>Giovanni Piotti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisa Gabanti</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esposito Pasquale, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marilena Gregorini, MD, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giulia Bedino, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesca Bosio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005 Jul 21;436(7049):356-62.</citation>
    <PMID>16034410</PMID>
  </results_reference>
  <results_reference>
    <citation>Graham TE, Yang Q, Bl√ºher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006 Jun 15;354(24):2552-63.</citation>
    <PMID>16775236</PMID>
  </results_reference>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2009</study_first_submitted>
  <study_first_submitted_qc>May 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2009</study_first_posted>
  <last_update_submitted>May 28, 2009</last_update_submitted>
  <last_update_submitted_qc>May 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Giovanni Piotti, MD</name_title>
    <organization>Unit Of Nephrology, Dialysis And Transplantation, IRCCS Fondazione Policlinico San Matteo, Pavia Italy</organization>
  </responsible_party>
  <keyword>Retinol Binding Protein 4</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Diabetes</keyword>
  <keyword>End Stage Renal Disease</keyword>
  <keyword>Dialysis</keyword>
  <keyword>Nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

